Bioatrix

Sydney, Australia Founded: 2012 • Age: 14 yrs Acquired By ZZ Biotech
Developing activated protein C (aPC)-based products primarily for wound healing
Request Access

About Bioatrix

Bioatrix is a company based in Sydney (Australia) founded in 2012 was acquired by ZZ Biotech in January 2016.. Bioatrix operates in a competitive market with competitors including QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others.

  • Headquarter Sydney, Australia
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    ZZ Biotech

    (Jan 12, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Bioatrix

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Bioatrix

Bioatrix has secured backing from 1 investor. Prominent investors backing the company include ZZ Biotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Genetically engineered proteins for stroke and brain disorders are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Bioatrix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Bioatrix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioatrix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Bioatrix

Bioatrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, MediWound, Ilya Pharma, Resolution Therapeutics and ProFibrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecules from plant extracts are developed for medical applications.
domain founded_year HQ Location
Enzymatic therapies for tissue repair and regeneration are developed.
domain founded_year HQ Location
Biological drugs for skin and mucosa wound treatment are developed.
domain founded_year HQ Location
Macrophage cell therapies are developed for inflammatory and liver diseases.
domain founded_year HQ Location
Powdered fibrin sealant for surgical bleeding
domain founded_year HQ Location
Topical formulations for corneal wounds, ulcers, and scars are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioatrix

Frequently Asked Questions about Bioatrix

When was Bioatrix founded?

Bioatrix was founded in 2012.

Where is Bioatrix located?

Bioatrix is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.

What does Bioatrix do?

Bioatrix is a regenerative medicine company primarily focussed on developing protein-based products for wound healing. It has licensed the technology based on the Activated Protein C (aPC) from the Sydney University. These proteins claim to have shown potential as a treatment for inflammatory skin diseases, such as psoriasis and eczema, and hypertrophic scarring. The company is currently working on phase 2 trials wound healing. In December 2015, ZZ Biotech acquired Bioatrix and since then it is working as its subsidiary.

Who are the top competitors of Bioatrix?

Bioatrix's top competitors include Ilya Pharma, QBiotics and Tempo Therapeutics.

Who are Bioatrix's investors?

Bioatrix has 1 investor. Key investors include ZZ Biotech.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available